KRISTEN LOHR: Open Payments
NPI 1023385457 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,086 in 78 payments from 35 companies in 2025. Trend: 2023 $2,937 · 2024 $2,062 · 2025 $2,086
Food & beverage: $1,983Education: $103
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $216 |
| Janssen Biotech, Inc. | 7 | $190 |
| Merck Sharp & Dohme LLC | 8 | $177 |
| E.R. Squibb & Sons, L.L.C. | 2 | $141 |
| AstraZeneca Pharmaceuticals LP | 4 | $132 |
| Genentech USA, Inc. | 5 | $120 |
| Lilly USA, LLC | 2 | $112 |
| PharmaEssentia USA Corporation | 3 | $98 |
| Stemline Therapeutics Inc. | 3 | $83 |
| ABBVIE INC. | 3 | $72 |
Products named: KEYTRUDA, OPDIVO, BESREMI, Orserdu, TECVAYLI, JAKAFI, LYNPARZA, Venclexta.
Industry payments across MD — which companies pay providers there.
